| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/16/2009 | WO2009047859A1 Granular jelly beverage for medication and process for producing the same |
| 04/16/2009 | WO2009047785A2 A non-aqueous topical solution of diclofenac and process for preparing the same |
| 04/16/2009 | WO2009047587A1 Magnetic, paramagnetic and/or superparamagnetic nanoparticles |
| 04/16/2009 | WO2009047537A1 Preparation for treating intestinal infection comprising oligosaccharides and insoluble cellular material |
| 04/16/2009 | WO2009047500A1 Novel conjugated proteins and peptides |
| 04/16/2009 | WO2009047434A2 Use of carriers as preservatives and pharmaceutical composition containing same |
| 04/16/2009 | WO2009046967A1 Aqueous ophthalmic formulations |
| 04/16/2009 | WO2009046541A1 MODULATION OF SIRPα - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR |
| 04/16/2009 | WO2009026306A3 Probiotic composition useful for dietary augmentation and/or combating disease states and adverse physiological conditions |
| 04/16/2009 | WO2008106503A8 Discrete size and shape specific pharmaceutical organic nanoparticles |
| 04/16/2009 | WO2008101187A3 Pro-drugs of peripheral phenolic opioid antagonists |
| 04/16/2009 | WO2008095603A3 Color-marked oligosaccharides or polysaccharides |
| 04/16/2009 | WO2008067027A3 Compositions of chkl inhibitors and cyclodextrin |
| 04/16/2009 | WO2008027218A3 Drug electrotransport with hydration measurement of hydratable reservoir |
| 04/16/2009 | WO2006119291A3 Superantibody synthesis and use in detection, prevention and treatment of disease |
| 04/16/2009 | WO2006119083A3 Treating gastrointestinal diseases with modulation of retonic acid |
| 04/16/2009 | WO2006083562A3 Method and multicomponent conjugates for treating cancer |
| 04/16/2009 | WO2006083276A3 Interferon-alpha polypeptides and conjugates |
| 04/16/2009 | WO2006062559A3 Device for enhancing tissue glucose processing |
| 04/16/2009 | WO2006023985A3 System and method for modifying a fluid for oral administration |
| 04/16/2009 | WO2006016282A3 Media indexer |
| 04/16/2009 | WO2005115477A3 Non-natural ribonuclease conjugates as cytotoxic agents |
| 04/16/2009 | WO2005069994A3 Folate conjugates and complexes |
| 04/16/2009 | WO2005016414A3 Use of receptor sequences for immobilizing gene vectors on surfaces |
| 04/16/2009 | US20090099268 Anti-adhesion membrane |
| 04/16/2009 | US20090099267 Polymers, compositions and methods of making the same |
| 04/16/2009 | US20090099266 Antifungal nail coat and method of use |
| 04/16/2009 | US20090099232 Injectable depot formulation comprising crystals of iloperidone |
| 04/16/2009 | US20090099225 Method for the production of propellant gas-free aerosols from aqueous medicament preparations |
| 04/16/2009 | US20090099202 External Preparation for Athlete's Foot Treatment |
| 04/16/2009 | US20090099149 Bioadhesive film |
| 04/16/2009 | US20090099115 A chemically-modified nucleic acid molecule that comprises a sense strand with or without the 3' TT overhang, and a separate antisense strand with or without the 3' TT overhang; pyrimidine modification; cancer |
| 04/16/2009 | US20090099082 Production of polyurethane foams |
| 04/16/2009 | US20090098634 Scleroprotein of an adeno associated virus with modified chromatographic properties, the production thereof and use of the same |
| 04/16/2009 | US20090098633 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 04/16/2009 | US20090098212 Acoustically sensitive drug delivery particle |
| 04/16/2009 | US20090098203 Mucoadhesive Tetracycline Formulations |
| 04/16/2009 | US20090098192 Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same |
| 04/16/2009 | US20090098177 Methods and devices for tissue repair |
| 04/16/2009 | US20090098176 Medical devices with triggerable bioadhesive material |
| 04/16/2009 | US20090098172 Surfactant, and emulsion cosmetic and liposome each containing the same |
| 04/16/2009 | US20090098161 removal of structural features of HIV that interfere with immune response. In particular, sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding, CD55 and CD59 removal prevent the binding of Complement Factor H; Acquired Immunodeficiency Syndrome |
| 04/16/2009 | US20090098160 sialic acid is removed to enhance immune recognition and to impair Complement Factor H binding; CD55 and CD59 removal prevents the binding of Complement Factor H; Acquired Immunodeficiency Syndrome |
| 04/16/2009 | US20090098157 Helicobacter Pylori Vaccination |
| 04/16/2009 | US20090098148 High efficiency tissue-specific compound delivery system using streptavadin-protein a fusion protein |
| 04/16/2009 | US20090098119 Antidotes for factor xa inhibitors and methods of using the same |
| 04/16/2009 | US20090098083 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 04/16/2009 | US20090098072 Antioxidants |
| 04/16/2009 | US20090095293 Dry powder inhalation system for transpulmonary administration |
| 04/16/2009 | CA2704009A1 Preparation, use of preparation for treatment, and method of treatment of intestinal infection |
| 04/16/2009 | CA2702217A1 Modulation of sirp.alpha. - cd47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor |
| 04/16/2009 | CA2702211A1 Extrudable and extruded compositions for delivery of bioactive agents, method of making same and method of using same |
| 04/16/2009 | CA2702173A1 Preparation for treating heart disease used in cell therapy |
| 04/16/2009 | CA2702082A1 Aqueous ophthalmic formulations |
| 04/16/2009 | CA2702057A1 Rapid acting injectable insulin compositions |
| 04/16/2009 | CA2702043A1 Compositions and methods for ribonuclease-based therapies |
| 04/16/2009 | CA2701857A1 A pharmaceutical composition for the sublingual administration of progesterone, and a method for its preparation |
| 04/16/2009 | CA2701777A1 Granular jelly beverage for medication and process for producing the same |
| 04/16/2009 | CA2701482A1 Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors |
| 04/16/2009 | CA2699788A1 Compositions comprising sphingosine 1 phosphate (s1p) receptor modulators |
| 04/16/2009 | CA2699090A1 Combination therapy with antibody-drug conjugates |
| 04/16/2009 | CA2698628A1 Use of carriers as preservatives and pharmaceutical composition containing same |
| 04/16/2009 | CA2697458A1 A novel non-aqueous topical solution of diclofenac and process for preparing the same |
| 04/15/2009 | EP2048157A1 Polynucleotide encoding the rg1 polypeptide |
| 04/15/2009 | EP2048156A1 Process for providing a temperature-stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
| 04/15/2009 | EP2047866A1 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 04/15/2009 | EP2047865A1 Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 04/15/2009 | EP2047864A1 Use of rpn2 gene expression inhibitor |
| 04/15/2009 | EP2047857A1 Agent for injection purposes comprising antibiotic, and solution for injection comprising the agent |
| 04/15/2009 | EP2047845A1 Adhesive preparation |
| 04/15/2009 | EP2047844A2 A method of microencapsulation |
| 04/15/2009 | EP2046895A2 Asymmetric fluoro-substituted polymethine dyes |
| 04/15/2009 | EP2046813A2 Protein-binding methotrexate derivatives, and medicaments containing the same |
| 04/15/2009 | EP2046452A2 Antibiotic composition |
| 04/15/2009 | EP2046393A2 Controlled release of phenolic opioids |
| 04/15/2009 | EP2046392A2 Radiodense conjugate |
| 04/15/2009 | EP2046391A2 Drug carriers, their synthesis, and methods of use thereof |
| 04/15/2009 | EP2046390A1 Linseed extract medicament for application to the eye |
| 04/15/2009 | EP2046389A2 Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease |
| 04/15/2009 | EP2046388A2 Formulations for parenteral delivery of compounds and uses thereof |
| 04/15/2009 | EP2046387A1 Masking the taste of compositions containing salt |
| 04/15/2009 | EP2046365A1 Pharmaceutical composition for treating autoimmune, allergic and inflammatory diseases and delivery method thereof |
| 04/15/2009 | EP2046360A2 Herbal compositions for the treatment of diseases of the oral cavity |
| 04/15/2009 | EP2046352A1 Fermented milk product and use thereof |
| 04/15/2009 | EP2046343A2 Formulations of radioprotective alpha, beta unsaturated aryl sulfones |
| 04/15/2009 | EP2046298A1 Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same |
| 04/15/2009 | EP2046291A1 Pharmaceutical suspensions comprising phenylephrine and method of preparation |
| 04/15/2009 | EP2046288A1 Hydrogels containing low molecular weight alginates and biostructures made therefrom |
| 04/15/2009 | EP2046284A1 Compositions for intranasal delivery of human insulin and uses thereof |
| 04/15/2009 | EP2046266A2 End-modified poly(beta-amino esters) and uses thereof |
| 04/15/2009 | EP2003130A9 Novel pyridine derivative having anti-helicobacter pylori activity |
| 04/15/2009 | EP1848459A4 Process for the preparation of polymer conjugates |
| 04/15/2009 | EP1797881B1 Medicinal composition with improved stability and reduced gelation properties |
| 04/15/2009 | EP1729732B1 Anionic hydrogel matrices with ph dependent modified release as drug carriers |
| 04/15/2009 | EP1551763B1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 04/15/2009 | EP1542668B1 Aripiprazole complex formulation and method |
| 04/15/2009 | EP1528930B1 Pharmaceutically active substance preparations and drugs that are capable of generating thrombin and/or that contain thrombin |
| 04/15/2009 | EP1480678B1 Treatment of ophthalmic disorders using urea and urea derivatives |
| 04/15/2009 | EP1458408B1 Liquid composition of factor vii polypeptides |
| 04/15/2009 | EP1446010B1 Stabilized azithromycin compositions |